The European Society for Translational Medicine (EUSTM) defines translational medicine (TM) as "an interdisciplinary branch of the biomedical field supported by three main pillars: bench side, bedside, and community." The purpose of TM is to improve prevention, diagnostics, and therapies by combining disciplines, resources, skills, and techniques within these pillars. As a result, translational medicine is a highly interdisciplinary subject whose main purpose is to bring together assets of various kinds within distinct pillars in order to significantly improve the global healthcare system. Clinical research and development are heavily reliant on translational medicine. It is a multidisciplinary area that brings together researchers, doctors, and patients in an endeavour to move breakthroughs from the lab to the clinic, as well as to supplement fundamental research with data from clinical trials. Translational medicine sits at the crossroads of basic research, which attempts to better understand disease causes, and clinical research, which evaluates the efficacy and safety of new treatments for patients. Translation of scientific discoveries into innovative medicines that improve patient health requires this collaborative discipline. Translational medicine brings together the expertise of academics, pharmacologists, and clinicians to evaluate new medicines and, as a result, speed up the entire drug development process. It can be used to treat any ailment.